Nuvalent, Inc.
Total Trades
254
Buys
2
Sells
142
Largest Trade
N/A
Insiders
10
Institutional Funds
183
Inst. Value
$1M+
Activist Filings
24
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $80.36 | Aug 1, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 4K | $27.85 | Aug 1, 2025 |
| Balcom Alexandra | CFO | SELL | $1M+ | 20K | $84.67 | Jul 17, 2025 |
| Balcom Alexandra | CFO | EXERCISE | $100K–$500K | 20K | $18.93 | Jul 17, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $82.27 | Jul 17, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $18.93 | Jul 17, 2025 |
| Pelish Henry E. | Chief Scientific O… | SELL | $500K+ | 8K | $80.31 | Jul 11, 2025 |
| Pelish Henry E. | Chief Scientific O… | EXERCISE | $100K–$500K | 6K | $28.75 | Jul 11, 2025 |
| Balcom Alexandra | CFO | SELL | $1M+ | 20K | $80.02 | Jul 1, 2025 |
| Balcom Alexandra | CFO | EXERCISE | $100K–$500K | 20K | $18.93 | Jul 1, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 4K | $27.85 | Jun 27, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $78.71 | Jun 27, 2025 |
| Pelish Henry E. | Chief Scientific O… | SELL | $500K+ | 11K | $79.88 | Jun 27, 2025 |
| Pelish Henry E. | Chief Scientific O… | EXERCISE | $100K–$500K | 11K | $28.78 | Jun 27, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $76.93 | Jun 17, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $27.85 | Jun 17, 2025 |
| Pelish Henry E. | Chief Scientific O… | EXERCISE | $1K–$15K | 200 | $28.59 | Jun 10, 2025 |
| Pelish Henry E. | Chief Scientific O… | SELL | $15K–$50K | 200 | $79.82 | Jun 10, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $50K–$100K | 4K | $20.69 | May 30, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $71.31 | May 30, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $69.60 | May 16, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $27.85 | May 16, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $74.56 | May 1, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $50K–$100K | 4K | $14.40 | May 1, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $68.94 | Apr 17, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $27.85 | Apr 17, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $50K–$100K | 4K | $16.92 | Mar 28, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $73.12 | Mar 28, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $75.87 | Mar 19, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $27.85 | Mar 19, 2025 |
| Shair Matthew | Director | SELL | $100K–$500K | 2K | $78.43 | Feb 25, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $27.85 | Feb 20, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $78.46 | Feb 20, 2025 |
| Shair Matthew | Director | SELL | $100K–$500K | 2K | $82.79 | Jan 29, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $75.99 | Jan 17, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $27.85 | Jan 17, 2025 |
| Pelish Henry E. | Chief Scientific O… | SELL | $100K–$500K | 2K | $79.68 | Jan 8, 2025 |
| Pelish Henry E. | Chief Scientific O… | GRANT | N/A | 19K | — | Jan 8, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $79.68 | Jan 8, 2025 |
| Noci Darlene | Chief Development … | GRANT | N/A | 19K | — | Jan 8, 2025 |
| Miller Deborah Ann | Chief Legal Officer | GRANT | N/A | 19K | — | Jan 8, 2025 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $100K–$500K | 3K | $79.68 | Jan 8, 2025 |
| Turner Christopher Durant | Chief Medical Offi… | GRANT | N/A | 19K | — | Jan 8, 2025 |
| Turner Christopher Durant | Chief Medical Offi… | SELL | $100K–$500K | 4K | $79.68 | Jan 8, 2025 |
| Balcom Alexandra | CFO | GRANT | N/A | 19K | — | Jan 8, 2025 |
| Balcom Alexandra | CFO | SELL | $100K–$500K | 4K | $79.68 | Jan 8, 2025 |
| Porter James Richard | President and CEO | GRANT | N/A | 56K | — | Jan 8, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 17K | $79.68 | Jan 8, 2025 |
| Shair Matthew | Director | SELL | $100K–$500K | 2K | $83.78 | Dec 26, 2024 |
| Balcom Alexandra | CFO | SELL | $500K+ | 10K | $95.79 | Dec 3, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 183 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1.9M | $1M+ | SH |
| STATE STREET CORP | 1.9M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 1.7M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| BRAIDWELL LP | 821K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 785K | $1M+ | SH |
| Fairmount Funds Management LLC | 728K | $1M+ | SH |
| NORGES BANK | 574K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 453K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 374K | $1M+ | SH |
| First Turn Management, LLC | 369K | $1M+ | SH |
| Candriam S.C.A. | 358K | $1M+ | SH |
| Pictet Asset Management Holding SA | 356K | $1M+ | SH |
| Affinity Asset Advisors, LLC | 323K | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 311K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 296K | $1M+ | SH |
| LORD, ABBETT & CO. LLC | 272K | $1M+ | SH |
| Defilade Capital Management, L.P. | 269K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 174K | $1M+ | SH |
| Aberdeen Group plc | 165K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 12, 2026
24.2%
22.9M shares
SC 13G · Jul 18, 2025
5.0%
3.3M shares
SC 13G/A · Apr 29, 2025
4.5%
2.9M shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 13, 2025
27.6%
23.6M shares
SC 13G/A · Jan 31, 2025
6.8%
4.5M shares
SC 13G/A · Nov 14, 2024
4.6%
3.0M shares
Paradigm Biocapital Advisors LP (Filed by)
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Nov 8, 2024
5.6%
3.6M shares
SC 13G · Oct 24, 2024
5.6%
3.6M shares
Deerfield Management Company, L.P.
SC 13G/A · May 15, 2024
34.0%
25.6M shares
Bain Capital Life Sciences Fund II, L.P. 2
SC 13D/A · Mar 29, 2024
4.1%
2.4M shares
Paradigm Biocapital Advisors LP (Filed by)
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Fairmount Funds Management LLC
SC 13G/A · Feb 14, 2024
3.4%
1.9M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.7%
3.3M shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 12, 2024
35.0%
25.5M shares
SC 13G · Jan 2, 2024
5.1%
2.9M shares
Paradigm Biocapital Advisors LP (Filed by)
SC 13G · Oct 30, 2023
0.0%
0 shares
Bain Capital Life Sciences Fund II, L.P. 2
SC 13D/A · Oct 20, 2023
4.2%
2.4M shares
Fairmount Funds Management LLC
SC 13G/A · Feb 14, 2023
5.5%
2.8M shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 10, 2023
39.3%
25.5M shares
Deerfield Management Company, L.P.
SC 13G/A · Nov 14, 2022
39.2%
25.5M shares
Fairmount Funds Management LLC
SC 13G · Nov 9, 2022
5.1%
2.6M shares
Bain Capital Life Sciences Fund II, L.P.
SC 13D/A · Nov 3, 2022
4.8%
2.4M shares
Deerfield Management Company, L.P.
SC 13G · Feb 11, 2022
45.1%
24.8M shares